1232 related articles for article (PubMed ID: 18838089)
1. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
2. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
Khang G; Cho JC; Lee JW; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(1):49-59. PubMed ID: 10436853
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
6. Development of biodegradable drug releasing polymeric cardiovascular stents and in vitro evaluation.
Sarisözen C; Arica B; Hincal AA; Caliş S
J Microencapsul; 2009 Sep; 26(6):501-12. PubMed ID: 18932059
[TBL] [Abstract][Full Text] [Related]
7. Drug release from PLGA microspheres attached to solids using supercritical CO₂.
Mulia K; Witkamp GJ; Dawes GJ; Fratila-Apachitei LE; Apachitei I; Duszczyk J; Pellikaan H
J Biomater Appl; 2011 Jan; 25(5):401-12. PubMed ID: 20042430
[TBL] [Abstract][Full Text] [Related]
8. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
Norton LW; Tegnell E; Toporek SS; Reichert WM
Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
[TBL] [Abstract][Full Text] [Related]
11. Controllable promotion of chondrocyte adhesion and growth on PVA hydrogels by controlled release of TGF-β1 from porous PLGA microspheres.
Nie L; Zhang G; Hou R; Xu H; Li Y; Fu J
Colloids Surf B Biointerfaces; 2015 Jan; 125():51-7. PubMed ID: 25437063
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
Kim HK; Chung HJ; Park TG
J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
[TBL] [Abstract][Full Text] [Related]
14. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
15. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres.
Dong CM; Guo YZ; Qiu KY; Gu ZW; Feng XD
J Control Release; 2005 Sep; 107(1):53-64. PubMed ID: 16005093
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of the fibronectin central cell binding domain from polymeric microspheres.
Bouissou C; Potter U; Altroff H; Mardon H; Van Der Walle C
J Control Release; 2004 Mar; 95(3):557-66. PubMed ID: 15023466
[TBL] [Abstract][Full Text] [Related]
17. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique.
Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903
[TBL] [Abstract][Full Text] [Related]
18. Open macroporous poly(lactic-co-glycolic Acid) microspheres as an injectable scaffold for cartilage tissue engineering.
Kang SW; La WG; Kim BS
J Biomater Sci Polym Ed; 2009; 20(3):399-409. PubMed ID: 19192363
[TBL] [Abstract][Full Text] [Related]
19. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
Xu Q; Czernuszka JT
J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
[TBL] [Abstract][Full Text] [Related]
20. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]